Search

everythinglearnresearchcommunity

for

Search:↓

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Pimecrolimus cream is not effective for treating alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

New treatments for lupus show promise, but more research is needed, especially for children.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.